razoxane has been researched along with Uterine Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blessing, JA; Conroy, J; DiSaia, PJ; Hatch, K; Homesley, HD; Twiggs, LB | 1 |
1 other study(ies) available for razoxane and Uterine Neoplasms
| Article | Year |
|---|---|
ICRF-159 (razoxane) in patients with advanced adenocarcinoma of the endometrium. A Gynecologic Oncology Group Study.
Topics: Adenocarcinoma; Adult; Aged; Drug Evaluation; Female; Humans; Middle Aged; Piperazines; Razoxane; Uterine Neoplasms | 1986 |